Pregnancy and prosthetic heart valves

The Lancet

Volumn 344, Issue 8931, 1994, Pages 1170-1172

  Ginsberg, J S ^a,b   Barron, W M ^a,b  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

BLEEDING; BLOOD PLACENTA BARRIER; CENTRAL NERVOUS SYSTEM MALFORMATION; CLINICAL TRIAL; DRUG CONTRAINDICATION; EMBRYOPATHY; FEMALE; FIRST TRIMESTER PREGNANCY; HEART VALVE PROSTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NOTE; OSTEOPOROSIS; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM; VALVULAR HEART DISEASE; VEIN THROMBOSIS;

EID: 0028019537     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)90501-0     Document Type: Article

References (14)

1. Outcome of pregnancy in women with valve prostheses
2. Maternal and fetal sequelae of anticoagulation during pregnancy
3. Risks of anticoagulant therapy in pregnant women with artificial heart valves
4. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy
5. Use of anticoagulants during pregnancy
6. Heparin
7. Establishing a therapeutic range for heparin therapy
8. Pregnancy outcome in women with cardiac valve prosthesis
9. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis
10. Heparin therapy during pregnancy
11. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin
12. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry
13. Heparin effect on bone density
14. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement